住院老年患者衰弱与死亡率关联在COVID-19感染与否间的比较:基于电子健康记录的回顾性观察研究
本研究为单中心回顾性队列研究,利用电子健康记录分析65岁及以上住院老年患者(n=1,071,其中285例COVID-19阳性)的衰弱水平与30天全因死亡率的关系。结果显示,COVID-19阴性队列中全因死亡率从非衰弱者的9%升至严重衰弱者的33%,而COVID-19阳性队列中各衰弱类别死亡率均在60%左右;校正分析中COVID-19感染死亡风险比为7.3(95%CI: 3.00, 18.0),衰弱(CFS)对死亡风险的增量贡献似乎很小。
要点
- COVID-19阳性住院老年患者各衰弱类别30天死亡率均约60%。
- COVID-19阴性队列死亡率从非衰弱9%升至严重衰弱33%。
- 校正后COVID-19感染死亡风险比为7.3(95%CI: 3.00, 18.0)。
核心结论
- 使用CFS测量的衰弱对COVID-19感染住院老年患者的死亡风险增量贡献似乎很小,而确诊COVID-19感染主导了死亡风险,校正后风险比为7.3(95%CI: 3.00, 18.0)。
研究设计与样本
- 单中心回顾性队列研究,利用电子健康记录分析65岁及以上住院老年患者,共1,071例有COVID-19检测结果,其中285例(27%)阳性。
主要发现
- COVID-19阴性队列30天全因死亡率从非衰弱者的9%升至严重衰弱者的33%,COVID-19阳性队列各衰弱类别死亡率均在60%左右。
- 校正分析中,COVID-19感染死亡风险比为7.3(95%CI: 3.00, 18.0),年龄、共病和疾病严重程度仅有小幅额外贡献。
关键数值与推荐
- 衰弱采用临床衰弱量表(CFS)评估,基线协变量包括人口学特征、早期预警评分、Charlson共病指数和衰弱,并与COVID-19状态链接。
临床怎么用
- 对住院老年患者,COVID-19感染状态是死亡风险的主导因素,衰弱评估(CFS)在COVID-19阳性者中对死亡风险的增量预测价值有限。
局限性
- 本研究为单中心回顾性观察性研究,原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to describe outcomes in hospitalised older people with different levels of frailty and COVID-19 infection. METHODS: We undertook a single-centre, retrospective cohort study examining COVID-19-related mortality using electronic health records, for older people (65 and over) with frailty, hospitalised with or without COVID-19 infection. Baseline covariates included demographics, early warning scores, Charlson Comorbidity Indices and frailty (Clinical Frailty Scale, CFS), linked to COVID-19 status. FINDINGS: We analysed outcomes on 1,071 patients with COVID-19 test results (285 (27%) were positive for COVID-19). The mean age at ED arrival was 79.7 and 49.4% were female. All-cause mortality (by 30 days) rose from 9 (not frail) to 33% (severely frail) in the COVID-negative cohort but was around 60% for all frailty categories in the COVID-positive cohort. In adjusted analyses, the hazard ratio for death in those with COVID-19 compared to those without COVID-19 was 7.3 (95% CI: 3.00, 18.0) with age, comorbidities and illness severity making small additional contributions. INTERPRETATION: In this study, frailty measured using the CFS appeared to make little incremental contribution to the hazard of dying in older people hospitalised with COVID-19 infection; illness severity and comorbidity had a modest association with the overall adjusted hazard of death, whereas confirmed COVID-19 infection dominated, with a sevenfold hazard for death.
引用
- Owen RK, Conroy SP, Taub N, et al. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records. Age Ageing. 2021. PMID: 32678866. doi:10.1093/ageing/afaa167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。